In 2010, important papers characterizing CD5− and/or CD5+ splenic marginal zone lymphoma (SMZL) were published, one in Haematologica and the other in J Clin Exp Hematopathol [1, 2]. This evidence concerns the gene CD5 and splenic marginal zone lymphoma.